Viz.ai, an artificial intelligence company in the service of health, has raised a $100 million funding round, reaching a valuation of $1.2 billion, elevating the technology to unicorn status.
The Series D round was led by Tiger Global and Insight Partners, but also included entities such as Scale Ventures, Kleiner Perkins, Threshold, Google Ventures, Sozo Ventures, CRV and Susa.
The investment will be used to boost the company’s growth, particularly with the global expansion of the platform and additional disease discovery and screening, as well as working to increase its customer base globally.
In Portugal, this investment put forward will allow the company to invest in the continued growth of the team, which currently has more than 30 employees. By the end of 2022, the technology company intends to double its number of employees, to a total of 500 employees globally in the engineering field.
Currently, in Portugal, he is recruiting for the positions of Android, iOS and Engineering Director. In terms of partnerships, the Viz.ai solution is already used by two hospitals in Europe, with clients in Portugal, Spain, UK, Ireland, Italy and Serbia.
«Last year, we achieved significant growth in Portugal, and we want to continue investing in it in 2022. As a key country for us, we intend to establish partnerships with a series of health entities throughout the territory and promote employment . Portuguese tech talent continues to amaze us and we believe it will play a key role in our mission to save lives and improve patient care globally,” highlights David Golan, Chief Technology Officer at Viz.ai.
“Writer. Analyst. Avid travel maven. Devoted twitter guru. Unapologetic pop culture expert. General zombie enthusiast.”
